FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to hematology, cardiology, endocrinology, and can be used for optimisation of functional reactivity of cardiovascular system (CVS) in patients with arterial hypertension with metabolic syndrome and heart failure of I-IIA stage. For this purpose, first, state of CVS functional reactivity at physicoemotional load is estimated. Systolic, diastolic, average dynamic (APavdyn.), heart rate (HR) are registered. On the basis of obtained parametres index of functional reactivity (IFR) before and after load is determined by formula IFR=(APavdyn.x HR)/100 (SU). Treatment is administered if IFR value increment is more than 20 SU. Treatment combines individually selected hypocaloric diet, daily swimming in swimming pool for not less than 15 minutes per day, morning hygienic gymnastics, therapeutic and preventive gymnastics and doing subdivided physical exercise during the day, and intake of valsartan 80 mg in the morning one time per day and pioglitazone 30 mg in the morning one time. Treatment duration is not less than 3 months.
EFFECT: method allows to diagnose failure of functional CVS reactivity, and combination of claimed methods of treatment allows to correct it efficiently, which favours prevention of complications of arterial hypertension with metabolic syndrome and heart failure of I-IIa stage.
2 ex
